Fundz
Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →

Kailera Therapeutics Appoints Nur Nicholson As Chief Technology Officer

PUBLIC · KLRAAug 11, 2026•about 5 hours ago

Position

Chief Technology Officer

Company

Kailera Therapeutics

Nur Nicholson
WalthamBiotechnologyHealth Care

Description

Kailera Therapeutics has announced the appointment of Nur Nicholson as Chief Technology Officer, effective August 31, 2026. Nur brings nearly three decades of experience in technical operations and manufacturing, which will be crucial as the company advances its obesity pipeline towards commercialization.

Company Information

Company

Kailera Therapeutics

Location

180 Third Ave 4th Floor

Waltham, Massachusetts, United States

About

Kailera Therapeutics (Kailera) is developing a broad, advanced, and differentiated portfolio of clinical-stage injectable and oral therapies for the treatment of obesity. Kailera’s most advanced program, KAI-9531 (being developed in China as HRS9531), is an injectable GLP-1/GIP receptor dual agonist that demonstrated positive clinical trial results in obesity in China. The Company is also advancing a diversified pipeline leveraging several mechanisms and routes of delivery. Kailera’s mission is to develop next-generation weight management therapies that give people the power to transform their lives and elevate their overall health.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Kailera Therapeutics's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.